Literature DB >> 19081729

Cardiac comorbidity is not a risk factor for mortality and morbidity following surgery for primary non-small cell lung cancer.

Pankaj Kumar Mishra1, Ragini Pandey, Michael J Shackcloth, James McShane, Antony D Grayson, Martyn H Carr, Richard D Page.   

Abstract

OBJECTIVE: We examined the effect of cardiac comorbidity on mortality and postoperative complications following surgery for primary non-small cell lung cancer.
METHODS: Between October 2001 to December 2005, 1067 consecutive patients underwent lung resection for primary cancer within a single centre; patient data was collected prospectively. Two hundred and seventy-one patients had a history of cardiac comorbidity, which included 196 angina, 118 myocardial infarction, 36 revascularisation, 10 congestive cardiac failure and 19 rhythm disorders (numbers not mutually exclusive). To account for differences in case-mix we used logistic regression to develop a propensity score for cardiac comorbidity group membership and then performed a propensity-matched analysis. Kaplan-Meier curves were used to assess follow-up mortality.
RESULTS: Patients with cardiac comorbidity were more likely to be hypertensive, have severe dyspnoea, diabetes, current or ex-smokers and were older. After performing propensity matching to account for these differences we successfully matched 199 patients with cardiac comorbidity to 398 patients with no cardiac history. There was no difference in in-hospital mortality (2.5% vs 3%, p=0.73), myocardial infarction (0.5% vs 0.3%, p>0.99), arrhythmia (15.6% vs 14.1%, p=0.62), renal failure (2% vs 1.5%, p=0.65), stroke (0.5% vs 0.3%, p>0.99), respiratory insufficiency (4% vs 3.3%, p=0.64), reintubation (1% vs 2.5%, p=0.35), tracheostomy (4% vs 7.8%, p=0.08), intensive care readmission (8.5% vs 6.5%, p=0.37) and length of stay (8 days vs 8 days, p=0.98). Three-year survival was similar (61.4% vs 56.2%, p=0.39). No differences in outcomes existed with different cardiac conditions.
CONCLUSION: With careful assessment and patient selection, patients with cardiac comorbidity were not found to be at increased risk of mortality and morbidity following lung resection for primary non-small cell lung cancer in a propensity-matched population.

Entities:  

Mesh:

Year:  2008        PMID: 19081729     DOI: 10.1016/j.ejcts.2008.10.029

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  9 in total

1.  [Preoperative evaluation and risk estimation in thoracic surgery].

Authors:  H Mutlak; S Czerner; H Winter; B Zwissler; P Lackermeier
Journal:  Anaesthesist       Date:  2010-10       Impact factor: 1.041

2.  Decrease in performance status after lobectomy mean poor prognosis in elderly lung cancer patients.

Authors:  Yo Kawaguchi; Jun Hanaoka; Yasuhiko Oshio; Masayuki Hashimoto; Tomoyuki Igarashi; Yoko Kataoka; Ryosuke Kaku; Yuki Namura; Akira Akazawa
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

3.  The effect of different comorbidities on survival of non-small cells lung cancer patients.

Authors:  Maria Iachina; Erik Jakobsen; Henrik Møller; Margreet Lüchtenborg; Anders Mellemgaard; Mark Krasnik; Anders Green
Journal:  Lung       Date:  2014-12-17       Impact factor: 2.584

4.  The impact of cardiovascular comorbidities on the outcome of surgery for non-small-cell lung cancer.

Authors:  Tomoyoshi Takenaka; Masakazu Katsura; Yasunori Shikada; Syuichi Tsukamoto; Sadanori Takeo
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-05

5.  Outcomes of lung cancer surgery in patients with coronary artery disease: a decade of experience at a single institution.

Authors:  Ryu Kanzaki; Masayoshi Inoue; Masato Minami; Yasushi Shintani; Soichiro Funaki; Tomohiro Kawamura; Meinoshin Okumura
Journal:  Surg Today       Date:  2016-05-19       Impact factor: 2.549

6.  The impact of decreasing cutoff values for maximal oxygen consumption (VO(2)max) in the decision-making process for candidates to lung cancer surgery.

Authors:  Gaetano Rocco; Tindaro Gatani; Massimo Di Maio; Ilernando Meoli; Antonello La Rocca; Nicola Martucci; Carmine La Manna; Francesco Stefanelli
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

Review 7.  Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?

Authors:  Sabina Mędrek; Sebastian Szmit
Journal:  Front Cardiovasc Med       Date:  2022-09-23

8.  Postoperative complications do not influence the pattern of early lung function recovery after lung resection for lung cancer in patients at risk.

Authors:  Maja Ercegovac; Dragan Subotic; Vladimir Zugic; Radoslav Jakovic; Dejan Moskovljevic; Slavisa Bascarevic; Natasa Mujovic
Journal:  J Cardiothorac Surg       Date:  2014-05-19       Impact factor: 1.637

9.  Impact of previous percutaneous coronary intervention on cardiovascular outcomes and mortality after lung cancer surgery: A nationwide study in Korea.

Authors:  Dong Woog Yoon; Dong Wook Shin; Jong Ho Cho; Jong-Hwan Lee; Jeong Hoon Yang; Kyungdo Han; Sang Hyun Park
Journal:  Thorac Cancer       Date:  2020-07-12       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.